Interestingly, the percentage of NKG2A+ CD69+ and NKG2C+ CD69+ NK cells was also significantly increased in both exhausted and CD16+ effector NK-cell subpopulations when compared to HD (p<0.001 COVID-19 patients vs HD; Figures 2G-H). This evidence concerns the gene KLRC2 and COVID-19.